Intrinsically disordered proteins (IDPs) are critical players in the dynamic control of diverse cellular processes, and provide potential new drug targets because their dysregulation is closely related to many diseases. This review focuses on several medicinal studies that have identified low-molecular-weight inhibitors of IDPs. In addition, clinically relevant liquid-liquid phase separations-which critically involve both intermolecular interactions between IDPs and their posttranslational modification-are analyzed to understand the potential of IDPs as new drug targets.
机构:Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA
Banjade, Sudeep
;
Rosen, Michael K.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USAUniv Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA
机构:Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA
Banjade, Sudeep
;
Rosen, Michael K.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USAUniv Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA